1. Home
  2. KD vs KYMR Comparison

KD vs KYMR Comparison

Compare KD & KYMR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Kyndryl Holdings Inc.

KD

Kyndryl Holdings Inc.

HOLD

Current Price

$12.81

Market Cap

2.8B

Sector

Technology

ML Signal

HOLD

Logo Kymera Therapeutics Inc.

KYMR

Kymera Therapeutics Inc.

HOLD

Current Price

$87.54

Market Cap

7.3B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
KD
KYMR
Founded
2020
2015
Country
United States
United States
Employees
80000
N/A
Industry
EDP Services
Medicinal Chemicals and Botanical Products
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.8B
7.3B
IPO Year
2021
2020

Fundamental Metrics

Financial Performance
Metric
KD
KYMR
Price
$12.81
$87.54
Analyst Decision
Buy
Strong Buy
Analyst Count
5
25
Target Price
$35.25
$107.21
AVG Volume (30 Days)
9.4M
763.1K
Earning Date
01-01-0001
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
170.95
N/A
EPS
0.77
N/A
Revenue
$15,057,000,000.00
$39,211,000.00
Revenue This Year
$3.96
$27.44
Revenue Next Year
$0.41
$0.40
P/E Ratio
$16.64
N/A
Revenue Growth
N/A
N/A
52 Week Low
$10.10
$19.45
52 Week High
$43.74
$103.00

Technical Indicators

Market Signals
Indicator
KD
KYMR
Relative Strength Index (RSI) 34.55 55.12
Support Level $11.34 $66.33
Resistance Level $13.93 $103.00
Average True Range (ATR) 0.78 4.84
MACD 0.36 0.17
Stochastic Oscillator 61.90 50.48

Price Performance

Historical Comparison
KD
KYMR

About KD Kyndryl Holdings Inc.

Kyndryl Holdings Inc is a technology services and infrastructure services provider company. It provides advisory, implementation, and managed services across a range of technology domains to help customers manage and modernize enterprise IT environments in support of their business and transformation objectives. The company's reportable segments consist of the following: Principal Markets which represents its operations in operations in Australia / New Zealand, Canada, France, Germany, India, Italy, Spain, Portugal, and the United Kingdom / Ireland, United States, Japan, and Strategic Markets. It derives maximum revenue from the United States.

About KYMR Kymera Therapeutics Inc.

Kymera Therapeutics Inc is a clinical-stage biopharmaceutical company dedicated to reinventing the treatment of human disease through the development of, differentiated medicines that address health problems and that meaningfully improve patients' lives. It is committed to novel technologies to address targets that have known disease-causing biology, but which have not been drugged, or have been inadequately drugged, often based on limitations of existing technologies. Its approach is intended to discover and develop a new generation of medicines in a disease-agnostic manner. Its product pipelines are STAT6, TYK2, and IRAK4.

Share on Social Networks: